Page 555 - Fluid, Electrolyte, and Acid-Base Disorders in Small Animal Practice

Fluid and Diuretic Therapy in Heart Failure 543

155. Sisson DD. Neuroendocrine evaluation of cardiac disease. 172. van der Zander K, Houben AJ, Kroon AA, et al. Does
Vet Clin North Am Small Anim Pract 2004;34:1105–26. brain natriuretic peptide have a direct renal effect in
156. Starling EH. The influence of mechanized factors on human hypertensives? Hypertension 2003;41:119–23.
lymph production. J Physiol (Lond) 1894;10:14–155. 173. Van Veldhuisen DJ, Genth-Zoth S, Brouwer J, et al.
157. Staub NC. Pathophysiology of pulmonary edema. High-versus low-dose ACE inhibition in chronic heart
In: Staub NC, Taylor AE, editors. Edema. New York: failure: a double-blind, placebo-controlled study of
Raven Press; 1984. p. 719–46. imidapril. J Am Coll Cardiol 1998;32:1811–8.
158. Suki WN, Rector Jr FC, Seldin DW. The site of action of 174. Vasko MR, Brown-Cartwright D, Knochel JP, et al. Furo-
furosemide and other sulfonamide diuretics in the dog. semide absorption altered in decompensated congestive
J Clin Invest 1965;44:1458–69. heart failure. Ann Intern Med 1985;102:314–8.
159. Suki WN. Renal hemodynamic consequences of angioten- 175. Vollmar AM, Montag C, Preusser U, et al. Atrial
sin-converting enzyme inhibition in congestive heart natriuretic peptide and plasma volume of dogs suffering
failure. Arch Intern Med 1989;149:669–73. from heart failure or dehydration. Zentralbl Veterinarmed
160. Sun Y, Weber KT. Cardiac remodelling by fibrous tissue- A 1994;41:548–57.
Role of local factors and circulating hormones. Ann Med 176. Vollmar AM, Preusser U, Gerbes AL, et al. Endothelin con-
1998;30(Suppl. 1):S3–S8. centration in plasma of healthy dogs and dogs with
161. Suzuki G, Morita H, Mishima T, et al. Effects of long- congestive heart failure, renal failure, diabetes mellitus, and
term monotherapy with eplerenone, a novel aldosterone hyperadrenocorticism. J Vet Intern Med 1995;9:105–11.
blocker, on progression of left ventricular dysfunction 177. Wang W. Chronic administration of aldosterone depresses
and remodeling in dogs with heart failure. Circulation baroreceptor reflex function in the dog. Hypertension
2002;106:2967–72. 1994;24:571–5.
162. Swales JD. Magnesium deficiency and diuretics. BMJ 178. Ware WA, Lund DD, Subieta AR, et al. Sympathetic acti-
1982;285:1377–8. vation in dogs with congestive heart failure caused by
163. Swan HJC, Ganz W, Forrester J, et al. Catheterization of chronic mitral valve disease and dilated cardiomyopathy.
the heart in man with use of a flow-directed balloon- J Am Vet Med Assoc 1990;197:1475–81.
tipped catheter. N Engl J Med 1970;283:447–51. 179. Watkins Jr L, Burton JA, Haber E, et al. The renin-angio-
164. Tachibana H, Cheng HJ, Ukai T, et al. Levosimendan tensin-aldosterone system in congestive failure in con-
improves LV systolic and diastolic performance at rest scious dogs. J Clin Invest 1976;57:1606–17.
and during exercise after heart failure. Am J Physiol 180. Weaver LJ, Carrico CJ. Congestive heart failure and
(Heart Circ Physiol) 2005;288:H914–H922. edema. In: Staub NC, Taylor AE, editors. Edema.
165. Taylor AE. Capillary fluid filtration: Starling forces and New York: Raven Press; 1984. p. 543–62.
lymph flow. Circ Res 1982;49:557–75. 181. Weber KT. Aldosterone and spironolactone in heart
166. Thames MD. Acetylstrophanthidin-induced reflex inhibi- failure [editorial]. N Engl J Med 1999;341:709–17.
tion of canine renal sympathetic nerve activity mediated 182. Weber KT. Furosemide in the long-term management of
by cardiac receptors with vagal afferents. Circ Res heart failure: the good, the bad, and the uncertain. J Am
1979;44:8–15. Coll Cardiol 2004;44:1308–10.
167. Thomas CJ, Woods RL. Haemodynamic action of B-type 183. Wiener-Kronish JP, Goldstein R, Matthay RA, et al. Lack
natriuretic peptide substantially outlasts its plasma half-life of association of pleural effusion with chronic pulmonary
in conscious dogs. Clin Exp Pharmacol Physiol arterial and right atrial hypertension. Chest
2003;30:369–75. 1987;92:967–70.
168. Thomas JA, Marks BH. Plasma norepinephrine in 184. Yatsu T, Tomura Y, Tahara A, et al. Pharmacological pro-
congestive heart failure. Am J Cardiol 1978;41:233–43. file of YM087, a novel nonpeptide dual vasopressin V1A
169. Thrall DE, Calvert CA. Radiographic evaluation of canine and V2 receptor antagonist, in dogs. Eur J Pharmacol
heartworm disease coexisting with right heart failure. 1997;321:225–30.
Vet Radiol 1983;24:124–6. 185. Zaca ` V, Rastogi S, Mishra S, Wang M, Sharov VG,
170. Uechi M, Matsuoka M, Kuwajima E, et al. The effects of Gupta RC, et al. Atenolol is inferior to metoprolol in
the loop diuretics furosemide and torsemide on diuresis in improving left ventricular function and preventing ven-
dogs and cats. J Vet Med Sci 2003;65:1057–61. tricular remodeling in dogs with heart failure. Cardiology
171. Uechi M, Sasaki T, Ueno K, et al. Cardiovascular and renal 2009;112(4):294–302.
effects of carvedilol in dogs with heart failure. J Vet Med 186. Zucker IH, Share L, Gilmore JP. Renal effects of left atrial
Sci 2002;64:469–75. distension in dogs with chronic congestive heart failure.
Am J Physiol 1979;236:H554–H560.